Kidney Stones and Risk of Narcotic Use.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 5 3 2019
medline: 19 6 2019
entrez: 5 3 2019
Statut: ppublish

Résumé

The rise in opioid related deaths and addiction has been linked to physician prescribing. Opioids are commonly prescribed to patients with renal colic due to nephrolithiasis. The aim of this study was to describe the relationship between nephrolithiasis and opioid use in the United States. Using the NHANES (National Health and Nutrition Examination Survey) we analyzed the relationship between a self-reported history of kidney stones and current opioid use in a nationally representative sample. Current opioid use was significantly greater among those who did vs did not report a history of kidney stones (10.9%, 95% CI 9.1-12.9 vs 6.1%, 95% CI 5.4-6.8). The prevalence of opioid use increased with the number of kidney stones passed, reaching 13.7% (95% CI 11.1-16.9) in subjects who had passed 2 or more stones (p <0.001). On multivariable logistic regression analysis adjusting for age, gender, smoking status, number of health care visits in the last year and comorbid conditions nephrolithiasis was independently associated with opioid based medication use (OR 1.27, 95% CI 1.07-1.49, p = 0.006). The association between a history of kidney stones and current narcotic use suggests that nephrolithiasis may be a risk factor for long-term opioid use. While this study is limited by the cross-sectional design and the absence of detailed stone histories, it adds to the evidence that altering pain management strategies may be beneficial in this population.

Identifiants

pubmed: 30829133
doi: 10.1097/JU.0000000000000197
doi:

Substances chimiques

Analgesics, Opioid 0
Prescription Drugs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-118

Commentaires et corrections

Type : CommentIn

Auteurs

Jonathan E Shoag (JE)

Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College , New York , New York.

Neal Patel (N)

Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College , New York , New York.

Lina Posada (L)

Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College , New York , New York.

Joshua A Halpern (JA)

Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College , New York , New York.

Talia Stark (T)

Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College , New York , New York.

Jim C Hu (JC)

Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College , New York , New York.

Brian H Eisner (BH)

Massachusetts General Hospital, Harvard Medical School , Boston , Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH